🔴 Axsome Therapeutics is trading 4.3% down today as rising oil and Treasury yields pressure equities

Axsome Therapeutics is trading at $194.39, down 4.29%, amid broad risk-off trading.

• No clear company-specific announcement or catalyst was identified for September 23, 2026; recent coverage centers on conferences, pipeline updates and Psych Congress data.
• Major U.S. indexes are lower as rising oil prices and Treasury yields pressure equity valuations. Biotech strength provides only a limited offset, leaving broader market sentiment—not company news—as the apparent immediate driver.